Literature DB >> 19129444

Evolution of the Sabin vaccine into pathogenic derivatives without appreciable changes in antigenic properties: need for improvement of current poliovirus surveillance.

Maria L Yakovenko1, Ekaterina A Korotkova, Olga E Ivanova, Tatyana P Eremeeva, Elena Samoilovich, Iryna Uhova, Gene V Gavrilin, Vadim I Agol.   

Abstract

The Sabin oral polio vaccine (OPV) may evolve into pathogenic viruses, causing sporadic cases and outbreaks of poliomyelitis. Such vaccine-derived polioviruses (VDPV) generally exhibit altered antigenicity. The current paradigm to distinguish VDPV from OPV and wild polioviruses is to characterize primarily those poliovirus isolates that demonstrate deviations from OPV in antigenic and genetic intratypic differentiation (ITD) tests. Here we report on two independent cases of poliomyelitis caused by VDPVs with "Sabin-like" properties in several ITD assays. The results suggest the existence of diverse pathways of OPV evolution and necessitate improvement of poliovirus surveillance, which currently potentially misses this class of VDPV.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19129444      PMCID: PMC2655595          DOI: 10.1128/JVI.02122-08

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  27 in total

Review 1.  Vaccine-derived polioviruses and the endgame strategy for global polio eradication.

Authors:  Olen M Kew; Roland W Sutter; Esther M de Gourville; Walter R Dowdle; Mark A Pallansch
Journal:  Annu Rev Microbiol       Date:  2005       Impact factor: 15.500

Review 2.  Molecular mechanisms of poliovirus variation and evolution.

Authors:  V I Agol
Journal:  Curr Top Microbiol Immunol       Date:  2006       Impact factor: 4.291

3.  Coupled mutations in the 5'-untranslated region of the Sabin poliovirus strains during in vivo passages: structural and functional implications.

Authors:  A R Muzychenko; S V Maslova; Y V Svitkin; E V Pilipenko; B K Nottay; O M Kew; V I Agol
Journal:  Virus Res       Date:  1991-10       Impact factor: 3.303

4.  The natural genomic variability of poliovirus analyzed by a restriction fragment length polymorphism assay.

Authors:  J Balanant; S Guillot; A Candrea; F Delpeyroux; R Crainic
Journal:  Virology       Date:  1991-10       Impact factor: 3.616

5.  Use of a multiple restriction fragment length polymorphism method for detecting vaccine-derived polioviruses in clinical samples.

Authors:  Natalia I Romanenkova; Sophie Guillot; Nadejda R Rozaeva; Radu Crainic; Maina A Bichurina; Francis Delpeyroux
Journal:  J Clin Microbiol       Date:  2006-09-06       Impact factor: 5.948

6.  Modulation of poliovirus replicative fitness in HeLa cells by deoptimization of synonymous codon usage in the capsid region.

Authors:  Cara Carthel Burns; Jing Shaw; Ray Campagnoli; Jaume Jorba; Annelet Vincent; Jacqueline Quay; Olen Kew
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

7.  Intratypic recombination among lineages of type 1 vaccine-derived poliovirus emerging during chronic infection of an immunodeficient patient.

Authors:  Chen-Fu Yang; Hour-Young Chen; Jaume Jorba; Hui-Chih Sun; Su-Ju Yang; Hsiang-Chi Lee; Yhu-Chering Huang; Tzou-Yien Lin; Pei-Jer Chen; Hiroyuki Shimizu; Yorihiro Nishimura; Andi Utama; Mark Pallansch; Tatsuo Miyamura; Olen Kew; Jyh-Yuan Yang
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

8.  Antigenic evolution of vaccine-derived polioviruses: changes in individual epitopes and relative stability of the overall immunological properties.

Authors:  Maria L Yakovenko; Elena A Cherkasova; Gennady V Rezapkin; Olga E Ivanova; Alexander P Ivanov; Tatyana P Eremeeva; Olga Y Baykova; Konstantin M Chumakov; Vadim I Agol
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

9.  Vaccine-derived polioviruses.

Authors:  Vadim I Agol
Journal:  Biologicals       Date:  2006-05-02       Impact factor: 1.856

10.  Neurovirulent vaccine-derived polioviruses in sewage from highly immune populations.

Authors:  Lester M Shulman; Yossi Manor; Danit Sofer; Rachel Handsher; Tiberio Swartz; Francis Delpeyroux; Ella Mendelson
Journal:  PLoS One       Date:  2006-12-20       Impact factor: 3.240

View more
  4 in total

1.  Correlation of mutations and recombination with growth kinetics of poliovirus vaccine strains.

Authors:  V Pliaka; Z Kyriakopoulou; D Tsakogiannis; I G A Ruether; C Gartzonika; S Levidiotou-Stefanou; A Krikelis; P Markoulatos
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-09-05       Impact factor: 3.267

2.  A Cluster of Paralytic Poliomyelitis Cases Due to Transmission of Slightly Diverged Sabin 2 Vaccine Poliovirus.

Authors:  Ekaterina A Korotkova; Anatoly P Gmyl; Maria L Yakovenko; Olga E Ivanova; Tatyana P Eremeeva; Liubov I Kozlovskaya; Armen K Shakaryan; Galina Y Lipskaya; Irina L Parshina; Nataliya V Loginovskikh; Nadezhda S Morozova; Vadim I Agol
Journal:  J Virol       Date:  2016-06-10       Impact factor: 5.103

3.  Are Circulating Type 2 Vaccine-derived Polioviruses (VDPVs) Genetically Distinguishable from Immunodeficiency-associated VDPVs?

Authors:  Kun Zhao; Jaume Jorba; Jing Shaw; Jane Iber; Qi Chen; Kelley Bullard; Olen M Kew; Cara C Burns
Journal:  Comput Struct Biotechnol J       Date:  2017-10-12       Impact factor: 7.271

4.  Controlling epidemics with transmissible vaccines.

Authors:  Scott L Nuismer; Ryan May; Andrew Basinski; Christopher H Remien
Journal:  PLoS One       Date:  2018-05-10       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.